CN Patent

CN117715639A — Sglt-2抑制剂用于预防和/或治疗非人哺乳动物中的肾脏病的用途

Assigned to Boehringer Ingelheim Vetmedica GmbH · Expires 2024-03-15 · 2y expired

What this patent protects

本发明涉及一种或多种SGLT‑2抑制剂或其药学上可接受的形式用于预防和/或治疗非人哺乳动物例如食肉动物，特别是猫或犬中的一种或多种肾脏病的用途。

USPTO Abstract

本发明涉及一种或多种SGLT‑2抑制剂或其药学上可接受的形式用于预防和/或治疗非人哺乳动物例如食肉动物，特别是猫或犬中的一种或多种肾脏病的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN117715639A
Jurisdiction
CN
Classification
—
Expires
2024-03-15
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim Vetmedica GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.